QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended March 31, 2026
OR
o
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from ________to ________
Commission File Number: 001-37399
__________________________________________
KEARNY FINANCIAL CORP.
(Exact name of registrant as specified in its charter)
__________________________________________
Maryland
30-0870244
(State or other jurisdiction of incorporation or organization)
(I.R.S. Employer Identification Number)
120 Passaic Ave., Fairfield, New Jersey
07004
(Address of principal executive offices)
(Zip Code)
Registrant’s telephone number, including area code
973-244-4500
__________________________________________
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, $0.01 par value
KRNY
The NASDAQ Stock Market LLC
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yesx No o
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yesx No o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filers,” “accelerated filers,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer
o
Accelerated filer
x
Non-accelerated filer
o
Smaller reporting company
o
Emerging growth company
o
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o No x
The number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date: April 30, 2026.
$0.01 par value common stock — 64,739,151 shares outstanding
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Principles of Consolidation
The unaudited consolidated financial statements include the accounts of Kearny Financial Corp. (the “Company”), its wholly-owned subsidiary, Kearny Bank (the “Bank”) and the Bank’s wholly-owned subsidiaries. The Company conducts its business principally through the Bank. Management prepared the unaudited consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”), including the elimination of all significant inter-company accounts and transactions during consolidation.
Basis of Presentation
The accompanying unaudited consolidated financial statements were prepared in accordance with instructions for Form 10-Q and Regulation S-X and do not include the information or footnotes necessary for a complete presentation of financial condition, income, comprehensive income, changes in stockholders’ equity and cash flows in conformity with GAAP. However, in the opinion of management, all adjustments (consisting of normal recurring adjustments) necessary for a fair presentation of the unaudited consolidated financial statements have been included. The results of operations for the nine months ended March 31, 2026 are not necessarily indicative of the results that may be expected for the entire fiscal year or any other period.
The data in the Consolidated Statement of Financial Condition at June 30, 2025 was derived from the Company’s 2025 Annual Report on Form 10-K. That data, along with the interim unaudited financial information presented in the Consolidated Statements of Financial Condition, Income, Comprehensive Income, Changes in Stockholders’ Equity and Cash Flows should be read in conjunction with the audited consolidated financial statements, including the notes thereto, included in the Company’s 2025 Annual Report on Form 10-K.
The accounting and reporting policies of the Company conform to U.S. GAAP and to general practice within the financial services industry. A discussion of these policies can be found in Note 1, Summary of Significant Accounting Policies, included in the Company’s 2025 Annual Report on Form 10-K. There have been no material changes to the Company’s significant accounting policies since June 30, 2025.
2. SUBSEQUENT EVENTS
The Company has evaluated events and transactions occurring subsequent to the statement of financial condition date of March 31, 2026, for items that should potentially be recognized or disclosed in these consolidated financial statements (unaudited). The evaluation was conducted through the date this document was filed.
On April 22, 2026, the Company declared a quarterly cash dividend of $0.11 per share, payable on May 20, 2026 to stockholders of record as of May 6, 2026.
3. RECENT ACCOUNTING PRONOUNCEMENTS
Accounting Standards Issued Not Yet Adopted
In November 2024, and as amended in January 2025, the FASB issued ASU 2024-03, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40), which requires improved disclosures about a public business entity’s expenses, including more detailed information about the types of expenses in commonly presented expense captions. The amendments in this update are effective for annual reporting periods beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027, although early adoption is permitted.
In January 2025, the FASB issued ASU 2025-01, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Clarifying the Effective Date. This ASU amends the effective date of ASU 2024-03 to clarify that all public business entities are required to adopt the guidance in annual reporting periods beginning after December 15, 2026, and interim periods within annual reporting periods beginning after December 15, 2027, with early adoption permitted. Adoption of ASU 2024-03 and ASU 2025-01 is not expected to have a significant impact on the Company's consolidated financial statements.
In September 2025, the FASB issued ASU 2025-06, Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40): Targeted Improvements to the Accounting for Internal-Use Software. This ASU clarifies the threshold entities apply to begin capitalizing costs and removes all references to project stages in ASC Subtopic 350-40. ASU No. 2025-06 is effective for all entities
for fiscal years beginning after December 15, 2027, and interim periods within those fiscal years. Early adoption is permitted as of the beginning of an annual reporting period.
In November 2025, the FASB issued ASU 2025-08, Financial Instruments-Credit Losses (Topic 326): Purchased Loans, which requires certain acquired loans (excluding credit cards) to be recorded at purchase price plus an allowance for expected credit losses (the “gross‑up” approach). The amendments introduce the concept of purchased seasoned loans and align their accounting with purchased credit‑deteriorated assets. The guidance is effective for fiscal years beginning after December 15, 2026, including interim periods, with early adoption permitted. The Company expects the amendments to affect the accounting for loans acquired in future business combinations or asset acquisitions.
4. SECURITIES
The following tables present the amortized cost, gross unrealized gains and losses and estimated fair values for available for sale securities and the amortized cost, gross unrecognized gains and losses and estimated fair values for held to maturity securities as of the dates indicated:
Excluding the balances of mortgage-backed securities, the following tables present the amortized cost and estimated fair values of debt securities available for sale and held to maturity, by contractual maturity, at March 31, 2026:
March 31, 2026
Amortized Cost
Fair Value
(In Thousands)
Available for sale debt securities:
Due in one year or less
$
—
$
—
Due after one year through five years
34,152
33,766
Due after five years through ten years
240,885
238,300
Due after ten years
168,371
167,333
Total
$
443,408
$
439,399
March 31, 2026
Amortized Cost
Fair Value
(In Thousands)
Held to maturity debt securities:
Due in one year or less
$
3,978
$
3,966
Due after one year through five years
1,688
1,671
Due after five years through ten years
—
—
Due after ten years
—
—
Total
$
5,666
$
5,637
The carrying value of securities pledged were as follows as of the dates presented below:
March 31, 2026
June 30, 2025
(In Thousands)
Securities pledged:
Pledged to secure public funds on deposit
$
125,047
$
475,234
Pledged for potential borrowings at the Federal Reserve Bank of New York
The following tables present the gross unrealized losses on securities and the estimated fair value of the related securities, aggregated by investment category and length of time that securities have been in a continuous unrealized loss position within the available for sale portfolio at March 31, 2026 and June 30, 2025:
March 31, 2026
Less than 12 Months
12 Months or More
Total
Fair Value
Unrealized Losses
Fair Value
Unrealized Losses
Number of Securities
Fair Value
Unrealized Losses
(Dollars in Thousands)
Securities Available for Sale:
Asset-backed securities
$
1,981
$
9
$
43,964
$
541
7
$
45,945
$
550
Collateralized loan obligations
157,295
502
8,405
4
14
165,700
506
Corporate bonds
15,989
36
95,630
4,383
20
111,619
4,419
Collateralized mortgage obligations
24,740
154
—
—
1
24,740
154
Commercial pass-through securities
—
—
107,248
20,089
7
107,248
20,089
Residential pass-through securities
48,514
392
302,720
73,098
95
351,234
73,490
Total
$
248,519
$
1,093
$
557,967
$
98,115
144
$
806,486
$
99,208
June 30, 2025
Less than 12 Months
12 Months or More
Total
Fair Value
Unrealized Losses
Fair Value
Unrealized Losses
Number of Securities
Fair Value
Unrealized Losses
(Dollars in Thousands)
Securities Available for Sale:
Asset-backed securities
$
29,860
$
493
$
18,526
$
323
7
$
48,386
$
816
Collateralized loan obligations
105,251
82
14,964
36
8
120,215
118
Corporate bonds
1,987
38
112,395
9,630
22
114,382
9,668
Commercial pass-through securities
—
—
109,817
20,377
7
109,817
20,377
Residential pass-through securities
21,942
109
314,871
83,069
99
336,813
83,178
Total
$
159,040
$
722
$
570,573
$
113,435
143
$
729,613
$
114,157
Available for sale securities are evaluated to determine if a decline in fair value below the amortized cost basis has resulted from a credit loss or from other factors. An impairment related to credit factors would be recorded through an allowance for credit losses. The allowance is limited to the amount by which the security’s amortized cost basis exceeds the fair value. An impairment that has not been recorded through an allowance for credit losses shall be recorded through other comprehensive income, net of applicable taxes. Investment securities will be written down to fair value through the Consolidated Statement of Income if management intends to sell, or may be required to sell, the securities before they recover in value. The issuers of these securities continue to make timely principal and interest payments and none of these securities were past due or were placed in nonaccrual status at March 31, 2026. The Company also monitors the credit quality of the issuers through credit ratings from various rating agencies. Credit ratings express opinions about the credit quality of a security and are utilized by the Company to make informed decisions. Management believes that the unrealized losses on these securities are a function of changes in market interest rates and credit spreads, not changes in credit quality. No allowance for credit losses was recorded at March 31, 2026 on available for sale securities.
At March 31, 2026, the held to maturity securities portfolio consisted of agency mortgage-backed securities and obligations of state and political subdivisions. The mortgage-backed securities are issued by U.S. government agencies and are implicitly guaranteed by the U.S. government. The obligations of state and political subdivisions in the portfolio are highly rated by major rating agencies and have a long history of no credit losses. The Company regularly monitors the obligations of state and political subdivisions sector of the market and reviews collectability including such factors as the financial condition of the issuers as well as credit ratings in effect as of the reporting period. No allowance for credit losses was recorded at March 31, 2026 on held to maturity securities.
As of March 31, 2026 and June 30, 2025, there were no holdings of debt securities of any one issuer, other than U.S. government sponsored entities and agencies, in an amount greater than 10% of stockholders’ equity.
The following table sets forth the composition of the Company’s loan portfolio at March 31, 2026 and June 30, 2025:
March 31, 2026
June 30, 2025
(In Thousands)
Commercial loans:
Multi-family mortgage
$
2,555,001
$
2,709,654
Nonresidential mortgage
1,012,422
986,556
Commercial business
201,277
138,755
Construction
207,765
177,713
Total commercial loans
3,976,465
4,012,678
One- to four-family residential mortgage
1,741,023
1,748,591
Consumer loans:
Home equity loans
61,379
50,737
Other consumer
2,377
2,533
Total consumer loans
63,756
53,270
Total loans
5,781,244
5,814,539
Unaccreted yield adjustments (1)
(2,063)
(1,602)
Total loans receivable, net of yield adjustments
$
5,779,181
$
5,812,937
___________________________
(1)At March 31, 2026 and June 30, 2025, included a fair value adjustment to the carrying amount of hedged one- to four-family residential mortgage loans.
Past Due Loans
Past due status is based on the contractual payment terms of the loans. The following tables present the payment status of past due loans as of March 31, 2026 and June 30, 2025, by loan segment:
Loans are generally placed on nonaccrual status when contractual payments become 90 or more days past due or when the Company does not expect to receive all principal and interest payments owed substantially in accordance with the terms of the loan agreement, regardless of past due status. Loans that become 90 days or more past due, but are well secured and in the process of collection, may remain on accrual status. Nonaccrual loans are generally returned to accrual status when all payments due are brought current and the Company expects to receive all remaining principal and interest payments owed substantially in accordance with the terms of the loan agreement. Payments received in cash on nonaccrual loans, including both the principal and interest portions of those payments, are generally applied to reduce the carrying value of the loan. The Company did not recognize interest income on non-accrual loans during the nine months ended March 31, 2026 and 2025.
The following tables present information relating to the Company’s nonperforming loans as of March 31, 2026 and June 30, 2025:
Performance Status March 31, 2026
90 Days and Over Past Due Accruing
Nonaccrual Loans with Allowance for Credit Losses
Nonaccrual Loans with no Allowance for Credit Losses
Total Nonperforming
Performing
Total
(In Thousands)
Multi-family mortgage
$
—
$
8,802
$
29,314
$
38,116
$
2,516,885
$
2,555,001
Nonresidential mortgage
—
—
5,679
5,679
1,006,743
1,012,422
Commercial business
—
206
330
536
200,741
201,277
Construction
—
—
2,755
2,755
205,010
207,765
One- to four-family residential mortgage
—
1,232
3,864
5,096
1,735,927
1,741,023
Home equity loans
—
83
114
197
61,182
61,379
Other consumer
—
—
—
—
2,377
2,377
Total loans
$
—
$
10,323
$
42,056
$
52,379
$
5,728,865
$
5,781,244
Performance Status June 30, 2025
90 Days and Over Past Due Accruing
Nonaccrual Loans with Allowance for Credit Losses
Nonaccrual Loans with no Allowance for Credit Losses
Total Nonperforming
Performing
Total
(In Thousands)
Multi-family mortgage
$
—
$
15,867
$
14,990
$
30,857
$
2,678,797
$
2,709,654
Nonresidential mortgage
—
—
5,763
5,763
980,793
986,556
Commercial business
—
1,930
293
2,223
136,532
138,755
Construction
—
—
—
—
177,713
177,713
One- to four-family residential mortgage
—
2,862
3,688
6,550
1,742,041
1,748,591
Home equity loans
—
188
16
204
50,533
50,737
Other consumer
—
—
—
—
2,533
2,533
Total loans
$
—
$
20,847
$
24,750
$
45,597
$
5,768,942
$
5,814,539
Loan Modifications Made to Borrowers Experiencing Financial Difficulty
The following table presents the amortized cost basis at March 31, 2026 and March 31, 2025 of loan modifications made to borrowers experiencing financial difficulty that were restructured during the three and nine months ended March 31, 2026 and 2025, by type of modification:
Payment Delay, Term Extension, and Interest Rate Reductions
Total
Percent of Total Class
(Dollars In Thousands)
Multi-family mortgage
$
—
$
—
$
24,678
$
24,678
0.97
%
Total
$
—
$
—
$
24,678
$
24,678
Nine Months Ended March 31, 2026
Payment Delay
Term Extension
Payment Delay, Term Extension, and Interest Rate Reductions
Total
Percent of Total Class
(Dollars In Thousands)
Multi-family mortgage
$
2,413
$
—
$
24,678
$
27,091
1.06
%
Commercial business
716
—
—
716
0.36
%
Total
$
3,129
$
—
$
24,678
$
27,807
Three Months Ended March 31, 2025
Payment Delay
Term Extension
Payment Delay, Term Extension, and Interest Rate Reductions
Total
Percent of Total Class
(Dollars In Thousands)
Multi-family mortgage
$
7,137
$
—
$
—
$
7,137
0.26
%
Commercial business
44
—
—
44
0.03
%
Total
$
7,181
$
—
$
—
$
7,181
Nine Months Ended March 31, 2025
Payment Delay
Term Extension
Payment Delay, Term Extension, and Interest Rate Reductions
Total
Percent of Total Class
(Dollars In Thousands)
Multi-family mortgage
$
31,181
$
—
$
2,606
$
33,787
1.24
%
Nonresidential mortgage
173
—
—
173
0.02
%
Commercial business
44
—
—
44
0.03
%
Total
$
31,398
$
—
$
2,606
$
34,004
No modifications involved forgiveness of principal for the three and nine months ended March 31, 2026 and March 31, 2025, respectively. At March 31, 2026 and March 31, 2025, there were no commitments to lend additional funds to borrowers experiencing financial difficulty whose terms have been restructured.
Of the loans restructured during the three and nine months ended March 31, 2026 and March 31, 2025, there were no subsequent defaults as of March 31, 2026. For restructured loans, a subsequent payment default is defined in terms of delinquency, when a principal or interest payment is 90 days past due or classified into non-accrual status during the reporting period.
The following table presents the performance status of the loans that were modified in the last twelve months to borrowers experiencing financial difficulties:
March 31, 2026
Current
30-89 Days Past Due
90 Days or More Past Due
Total Past Due
Non-Accrual
(Dollars In Thousands)
Multi-family mortgage
$
30,369
$
—
$
—
$
—
$
3,277
Commercial business
716
—
—
—
—
Total
$
31,085
$
—
$
—
$
—
$
3,277
June 30, 2025
Current
30-89 Days Past Due
90 Days or More Past Due
Total Past Due
Non-Accrual
(Dollars In Thousands)
Multi-family mortgage
$
22,571
$
2,582
$
8,564
$
11,146
$
14,515
Nonresidential mortgage
169
—
—
—
169
Commercial business
44
—
—
—
44
Total
$
22,784
$
2,582
$
8,564
$
11,146
$
14,728
Individually Analyzed Loans
Individually analyzed loans include loans which do not share similar risk characteristics with other loans. Loans previously modified as TDRs and loan modifications made to borrowers experiencing financial difficulty are generally evaluated for individual impairment. However, after a period of sustained repayment performance which permits the credit to be returned to accrual status, the loans are generally removed from individual impairment analysis and returned to its corresponding pool. As of March 31, 2026, the carrying value of individually analyzed loans, including loans acquired with deteriorated credit quality that were individually analyzed, totaled $52.4 million, of which $46.0 million were considered collateral dependent.
For collateral dependent loans where management has determined that foreclosure of the collateral is probable, or where the borrower is experiencing financial difficulty and repayment of the loan is to be provided substantially through the operation or sale of the collateral, the allowance for credit losses is measured based on the difference between the fair value of the collateral, less costs to sell, and the amortized cost basis of the loan as of the measurement date. See Note 12 for additional disclosure regarding fair value of individually analyzed collateral dependent loans.
The following table presents the carrying value and related allowance of collateral dependent individually analyzed loans at the dates indicated:
March 31, 2026
June 30, 2025
Carrying Value
Related Allowance
Carrying Value
Related Allowance
(In Thousands)
Commercial loans:
Multi-family mortgage
$
37,972
$
886
$
30,808
$
1,377
Nonresidential mortgage (1)
4,697
—
4,697
—
Commercial business (2)
53
—
—
—
Construction
2,755
—
—
—
Total commercial loans
45,477
886
35,505
1,377
One- to four-family residential mortgage (2)
516
—
2,264
—
Consumer loans:
Home equity loans (2)
14
—
16
—
Total
$
46,007
$
886
$
37,785
$
1,377
___________________________
(1)Secured by income-producing nonresidential property.
(2)Secured by one- to four-family residential properties.
The Company categorizes loans into risk categories based on relevant information about the ability of borrowers to service their debt such as: current financial information, historical payment experience, credit documentation, public information, and current economic trends, among other factors. The Company analyzes loans individually to classify the loans as to credit risk. The Company uses the following definitions for risk ratings:
Pass – Loans that are well protected by the current net worth and paying capacity of the obligor (or guarantors, if any) or by the fair value, less cost to acquire and sell, of any underlying collateral in a timely manner.
Special Mention – Loans which do not currently expose the Company to a sufficient degree of risk to warrant an adverse classification but have some credit deficiencies or other potential weaknesses.
Substandard – Loans which are inadequately protected by the paying capacity and net worth of the obligor or the collateral pledged, if any. Substandard assets include those characterized by the distinct possibility that the Company will sustain some loss if the deficiencies are not corrected.
Doubtful – Loans which have all of the weaknesses inherent in those classified as Substandard, with the added characteristic that the weaknesses present make collection or liquidation in full highly questionable and improbable, on the basis of currently existing facts, conditions and values.
Loss – Loans which are considered uncollectible or of so little value that their continuance as assets is not warranted.
The following table presents the risk category of loans and current period gross charge-offs as of March 31, 2026 by loan segment and vintage year:
The Company may obtain physical possession of real estate collateralizing mortgage loans through foreclosure or in‑substance repossession. Such real estate may include one‑ to four‑family residential properties securing residential mortgage loans and nonresidential properties securing nonresidential mortgage loans.
As of March 31, 2026, the Company held no residential or nonresidential real estate classified as other real estate owned (“OREO”) that was acquired through foreclosure. At that date, the Company had three residential mortgage loans with aggregate carrying values totaling $842,000, and 13 commercial mortgage loans with aggregate carrying values totaling $35.4 million, that were in the process of foreclosure.
As of June 30, 2025, the Company likewise held no residential or nonresidential OREO acquired through foreclosure. At that date, the Company held three residential mortgage loans with aggregate carrying values totaling $2.2 million and six commercial mortgage loans with aggregate carrying values totaling $23.7 million, that were in the process of foreclosure.
6. ALLOWANCE FOR CREDIT LOSSES
Allowance for Credit Losses on Loans Receivable
The following tables present the balance of the allowance for credit losses at March 31, 2026 and June 30, 2025. The balance of the allowance for credit losses is based on an expected loss methodology, referred to as the “CECL” methodology. The tables identify the valuation allowances attributable to specifically identified impairments on individually analyzed loans, including those acquired with deteriorated credit quality, as well as valuation allowances for impairments on loans collectively evaluated. The tables include the underlying balance of loans receivable applicable to each category as of those dates.
Allowance for Credit Losses March 31, 2026
Loans acquired with deteriorated credit quality individually analyzed
Loans acquired with deteriorated credit quality collectively evaluated
Loans individually analyzed
Loans collectively evaluated
Total allowance for credit losses
(In Thousands)
Multi-family mortgage
$
—
$
—
$
886
$
22,164
$
23,050
Nonresidential mortgage
—
15
—
7,787
7,802
Commercial business
—
6
45
2,567
2,618
Construction
—
—
—
1,437
1,437
One- to four-family residential mortgage
—
83
25
9,109
9,217
Home equity loans
—
—
—
499
499
Other consumer
—
—
—
100
100
Total loans
$
—
$
104
$
956
$
43,663
$
44,723
Balance of Loans Receivable March 31, 2026
Loans acquired with deteriorated credit quality individually analyzed
Loans acquired with deteriorated credit quality collectively evaluated
Changes in the Allowance for Credit Losses Nine Months Ended March 31, 2026
Balance at June 30, 2025
Charge-offs
Recoveries
Provision for (reversal of) credit losses
Balance at March 31, 2026
(In Thousands)
Multi-family mortgage
$
24,906
$
(1,195)
$
—
$
(661)
$
23,050
Nonresidential mortgage
6,938
(5)
—
869
7,802
Commercial business
2,428
(1,214)
109
1,295
2,618
Construction
1,155
—
—
282
1,437
One- to four-family residential mortgage
10,180
(47)
19
(935)
9,217
Home equity loans
490
(11)
—
20
499
Other consumer
94
—
—
6
100
Total loans
$
46,191
$
(2,472)
$
128
$
876
$
44,723
Changes in the Allowance for Credit Losses Three Months Ended March 31, 2025
Balance at December 31, 2024
Charge-offs
Recoveries
Provision for (reversal of) credit losses
Balance at March 31, 2025
(In Thousands)
Multi-family mortgage
$
24,880
$
—
$
—
$
(220)
$
24,660
Nonresidential mortgage
6,479
(332)
—
529
6,676
Commercial business
1,563
(40)
4
(10)
1,517
Construction
1,157
—
—
(34)
1,123
One- to four-family residential mortgage
9,855
—
—
103
9,958
Home equity loans
421
—
—
(4)
417
Other consumer
102
—
—
2
104
Total loans
$
44,457
$
(372)
$
4
$
366
$
44,455
Changes in the Allowance for Credit Losses Nine Months Ended March 31, 2025
Balance at June 30, 2024
Charge-offs
Recoveries
Provision for (reversal of) credit losses
Balance at March 31, 2025
(In Thousands)
Multi-family mortgage
$
24,125
$
—
$
—
$
535
$
24,660
Nonresidential mortgage
6,125
(830)
—
1,381
6,676
Commercial business
1,573
(242)
14
172
1,517
Construction
1,230
—
—
(107)
1,123
One- to four-family residential mortgage
11,461
(2)
2
(1,503)
9,958
Home equity loans
349
(2)
—
70
417
Other consumer
76
(5)
—
33
104
Total loans
$
44,939
$
(1,081)
$
16
$
581
$
44,455
The allowance for credit losses on loans decreased from $46.2 million at June 30, 2025 to $44.7 million as of March 31, 2026. The decrease was primarily due to a decrease in individually analyzed reserves on commercial and multi-family mortgage loans, resulting from net charge-offs, and a decrease in the balance of loans receivable, partially offset by quantitative and qualitative risk factor adjustments across different loan segments.
Allowance for Credit Losses on Off Balance Sheet Commitments
The following table presents the activity in the allowance for credit losses on off balance sheet commitments recorded in other non-interest expense for the three and nine months ended March 31, 2026 and 2025:
Three Months Ended March 31,
Nine Months Ended March 31,
2026
2025
2026
2025
(In Thousands)
Balance at beginning of the period
$
1,340
$
953
$
1,129
$
796
(Reversal of) provision for credit losses
(86)
37
125
194
Balance at end of the period
$
1,254
$
990
$
1,254
$
990
7. DEPOSITS
Deposits at March 31, 2026 and June 30, 2025 are summarized as follows:
March 31, 2026
June 30, 2025
(In Thousands)
Non-interest-bearing demand
$
631,506
$
582,045
Interest-bearing demand
2,375,565
2,362,222
Savings
763,016
754,376
Certificates of deposits
1,958,995
1,976,574
Total deposits
$
5,729,082
$
5,675,217
Certificates of deposits with balances of $250,000 or more at March 31, 2026 and June 30, 2025, totaled approximately $1.0 billion in each period, respectively. The Bank’s deposits are insurable to applicable limits by the FDIC.
Deposit balances at March 31, 2026 reflect a migration of $69.8 million from a consumer interest bearing product to a non-interest bearing product as part of the Company’s repricing strategy.
8. BORROWINGS
Borrowings at March 31, 2026 and June 30, 2025 consisted of the following:
March 31, 2026
June 30, 2025
(In Thousands)
FHLB advances
$
900,000
$
1,106,491
Total fixed-rate advances
900,000
1,106,491
Overnight borrowings (1)
160,000
150,000
Total borrowings
$
1,060,000
$
1,256,491
___________________________
(1)At March 31, 2026 and June 30, 2025 there were FHLB overnight line of credit borrowings of $160.0 million and $150.0 million, respectively.
Fixed rate advances from the FHLB of New York mature as follows:
March 31, 2026
June 30, 2025
Balance
Weighted Average Interest Rate
Balance
Weighted Average Interest Rate
(Dollars in Thousands)
By remaining period to maturity:
Less than one year
$
700,000
3.82
%
$
906,500
4.44
%
One to two years
200,000
3.98
%
—
—
Two to three years
—
—
200,000
3.98
%
Three to four years
—
—
—
—
Four to five years
—
—
—
—
Greater than five years
—
—
—
—
Total advances
900,000
3.86
%
1,106,500
4.36
%
Unamortized fair value adjustments
—
(9)
Total advances, net of fair value adjustments
$
900,000
$
1,106,491
At March 31, 2026, FHLB advances and overnight line of credit borrowings were collateralized by the FHLB capital stock owned by the Bank and mortgage loans with carrying values of approximately $2.87 billion. At June 30, 2025, such borrowings were collateralized by the FHLB capital stock owned by the Bank and mortgage loans with aggregate carrying values of approximately $3.24 billion.
At March 31, 2026, the Company also maintained available secured borrowing capacity of $2.45 billion with the FHLB and the Federal Reserve Discount Window, which was supported by pledged collateral with a book value of approximately $4.5 billion.
9. DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES
Risk Management Objective of Using Derivatives
The Company uses various financial instruments, including derivatives, to manage its exposure to interest rate risk. The Company’s derivative financial instruments are used to manage differences in the amount, timing, and duration of the Company’s known or expected cash receipts and its known or expected cash payments principally related to specific wholesale funding positions and assets.
Fair Values of Derivative Instruments on the Statement of Financial Condition
The tables below present the fair value of the Company’s derivative financial instruments as well as their classification on the Statements of Financial Condition as of March 31, 2026 and June 30, 2025:
The Company uses derivatives to add stability to interest expense and interest income and to manage its exposure to interest rate movements. The Company has entered into interest rate swaps, interest rate caps and an interest rate floor as part of its interest rate risk management strategy. These interest rate products are designated as cash flow hedges. As of March 31, 2026, the Company had a total of 17 interest rate swaps, caps and collars with a total notional amount of $1.95 billion hedging specific wholesale funding and deposits, and two interest rate floors with a notional amount of $250.0 million hedging floating-rate available for sale securities.
For derivatives designated as cash flow hedges, the gain or loss on the derivative is recorded in other comprehensive income, net of tax, and subsequently reclassified into interest expense in the same period during which the hedged transaction affects earnings.
For cash flow hedges on the Company’s wholesale funding positions and deposits, amounts reported in accumulated other comprehensive income (loss) related to derivatives will be reclassified to interest expense as interest payments are made. During the three and nine months ended March 31, 2026, the Company reclassified a gain of $2.9 million and $12.4 million, respectively, as a reduction in interest expense. During the next twelve months, the Company estimates that $2.7 million will be reclassified as a reduction in interest expense.
For cash flow hedges on the Company’s assets, amounts reported in accumulated other comprehensive income (loss) related to derivatives will be reclassified to interest income as interest payments are received on the Company’s hedged variable rate assets. During the three and nine months ended March 31, 2026, the Company reclassified a gain of $61,000 and $176,000, respectively,to interest income. During the next twelve months, the Company estimates that $232,000 will be reclassified as an increase in interest income.
The table below presents the pre-tax effects of the Company’s derivative instruments designated as cash flow hedges on the Consolidated Statements of Income for the three and nine months ended March 31, 2026 and 2025:
Three Months Ended March 31,
Nine Months Ended March 31,
2026
2025
2026
2025
(In Thousands)
Amount of gain (loss) recognized in other comprehensive income
$
5,842
$
(3,987)
$
6,602
$
(5,759)
Amount of gain reclassified from accumulated other comprehensive income to interest expense
$
2,914
$
5,305
$
12,394
$
21,042
Amount of gain (loss) reclassified from accumulated other comprehensive income to interest income
$
61
$
162
$
176
$
(209)
Fair Value Hedges of Interest Rate Risk
The Company is exposed to changes in the fair value of certain of its fixed-rate assets due to changes in benchmark interest rates. The Company uses interest rate swaps to manage its exposure to changes in fair value on these instruments attributable to changes in the designated benchmark interest rate. Interest rate swaps designated as fair value hedges involve the payment of fixed-rate amounts to a counterparty in exchange for the Company receiving variable-rate payments over the life of the agreements without the exchange of the underlying notional amount. Such derivatives are used to hedge the changes in fair value of certain of its pools of fixed-rate assets. As of March 31, 2026, the Company had five interest rate swaps with a notional amount of $675.0 million hedging fixed-rate residential mortgage loans.
For derivatives designated and that qualify as fair value hedges, the gain or loss on the derivatives as well as the offsetting loss or gain on the hedged item attributable to the hedged risk are recognized in interest income.
The table below presents the effects of the Company’s derivative instruments designated as fair value hedges on the Consolidated Statements of Income for the three and nine months ended March 31, 2026 and March 31, 2025:
Three Months Ended March 31,
Nine Months Ended March 31,
2026
2025
2026
2025
(In Thousands)
(Loss) gain on hedged items recorded in interest income on loans
$
(3,073)
$
3,718
$
(2,142)
$
9,908
Gain (loss) on hedges recorded in interest income on loans
As of March 31, 2026 and June 30, 2025, the following amounts were recorded on the Statement of Financial Condition related to cumulative basis adjustment for fair value hedges:
March 31, 2026
June 30, 2025
(In Thousands)
Loans receivable:
Carrying amount of the hedged assets(1)
$
675,595
$
777,737
Fair value hedging adjustment included in the carrying amount of the hedged assets
$
595
$
2,737
___________________________________
(1)This amount includes the amortized cost basis of the closed portfolios of loans receivable used to designate hedging relationships in which the hedged item is the stated amount of assets in the closed portfolios anticipated to be outstanding for the designated hedge period. At March 31, 2026 and June 30, 2025, the amortized cost basis of these closed portfolios used in these hedging relationships was $1.09 billion and $1.24 billion, respectively.
Offsetting Derivatives
The tables below present a gross presentation, the effects of offsetting, and a net presentation of the Company’s derivatives in the Consolidated Statements of Financial Condition as of March 31, 2026 and June 30, 2025, respectively. The net amounts presented for derivative assets or liabilities can be reconciled to the tabular disclosure of fair value. The tabular disclosure of fair value provides the location that derivative assets and liabilities are presented on the Consolidated Statements of Financial Condition.
The Company has agreements with each of its derivative counterparties that contain a provision where if the Company defaults on any of its indebtedness, then the Company could also be declared in default on its derivative obligations and could be required to terminate its derivative positions with the counterparty. The Company also has agreements with its derivative counterparties that contain a provision where if the Company fails to maintain its status as a well-capitalized institution, then the Company could be required to terminate its derivative positions with the counterparty. As of March 31, 2026 and June 30, 2025, one of the Company’s derivatives was in a net liability position.
As required under the enforceable master netting arrangement with its derivatives counterparties, at March 31, 2026 the Company was not required to post financial collateral. At June 30, 2025, the Company was required to post financial collateral of $4.7 million, which is included in cash and cash equivalents on the Consolidated Statements of Financial Condition.
In addition to the derivative instruments noted above, the Company’s pipeline of loans held for sale at March 31, 2026 and June 30, 2025, included $19.3 million and $11.1 million, respectively, of in process loans whose terms included interest rate locks to borrowers, which are considered free-standing derivative instruments whose fair values are not material to the Company’s financial condition or results of operations.
10. BENEFIT PLANS
Components of Net Periodic Expense
The following table sets forth the aggregate net periodic benefit expense for the Bank’s Benefit Equalization Plan, Postretirement Welfare Plan, Directors’ Consultation and Retirement Plan, Atlas Bank Retirement Income Plan and Supplemental Executive Retirement Plan:
Three Months Ended March 31,
Nine Months Ended March 31,
Affected Line Item in the Consolidated Statements of Income
2026
2025
2026
2025
(In Thousands)
Service cost
$
154
$
18
$
450
$
54
Salaries and employee benefits
Interest cost
108
97
316
277
Other expense
Accretion of unrecognized gain
(36)
(26)
(107)
(80)
Other expense
Expected return on assets
(22)
(23)
(67)
(68)
Other expense
Net periodic benefit cost
$
204
$
66
$
592
$
183
2021 Equity Incentive Plan
During the three months ended March 31, 2026, the Company did not grant any restricted stock units (“RSUs”) and during the nine months ended March 31, 2026, the Company granted 484,802 RSUs comprised of 350,868 service-based RSUs and 133,934 performance-based RSUs. The service-based RSUs will vest in three tranches over a period of three years and the performance-based RSUs will cliff vest upon the achievement of performance measures over the three-year period ending June 30, 2028. The number of performance-based RSUs that will vest, if any, will depend on whether, and to what extent, the performance measures are achieved. Common stock will be issued from authorized shares upon the vesting of the RSUs.
Fair value is the exchange price that would be received for an asset or paid to transfer a liability (exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. There are three levels of inputs that may be used to measure fair values:
Level 1:
Quoted prices (unadjusted) for identical assets or liabilities in active markets that the entity has the ability to access as of the measurement date.
Level 2:
Inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly or indirectly. These might include quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the asset or liability or inputs that are derived principally from, or corroborated by, market data by correlation or other means.
Level 3:
Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. Level 3 assets and liabilities include financial instruments whose value is determined using pricing models, discounted cash flow methodologies, or similar techniques, as well as instruments for which the determination of fair value requires significant management judgment or estimation.
Assets and Liabilities Measured on a Recurring Basis:
The following methods and significant assumptions were used to estimate the fair values as of March 31, 2026 and June 30, 2025:
Investment Securities Available for Sale
The Company’s available for sale investment securities are reported at fair value utilizing Level 2 inputs. For these securities, the Company obtains fair value measurements from an independent pricing service. The fair value measurements consider observable data that may include dealer quotes, market spreads, cash flows, the U.S. Treasury yield curve, live trading levels, trade execution data, market consensus prepayment speeds, credit information and the securities’ terms and conditions, among other things. From time to time, the Company validates prices supplied by the independent pricing service by comparison to prices obtained from third-party sources or derived using internal models.
Derivatives
The Company has contracted with a third party vendor to provide periodic valuations for its interest rate derivatives to determine the fair value of its interest rate contracts. The vendor utilizes standard valuation methodologies applicable to interest rate derivatives such as discounted cash flow analysis and extensions of the Black-Scholes model. Such valuations are based upon readily observable market data and are therefore considered Level 2 valuations by the Company.
Quoted Prices in Active Markets for Identical Assets (Level 1)
Significant Other Observable Inputs (Level 2)
Significant Unobservable Inputs (Level 3)
Total
(In Thousands)
Assets:
Debt securities available for sale:
Asset-backed securities
$
—
$
59,498
$
—
$
59,498
Collateralized loan obligations
—
323,245
—
323,245
Corporate bonds
—
140,117
—
140,117
Total debt securities
—
522,860
—
522,860
Mortgage-backed securities available for sale:
Residential pass-through securities
—
357,319
—
357,319
Commercial pass-through securities
—
132,790
—
132,790
Total mortgage-backed securities
—
490,109
—
490,109
Total securities available for sale
$
—
$
1,012,969
$
—
$
1,012,969
Interest rate contracts
$
—
$
16,745
$
—
$
16,745
Total assets
$
—
$
1,029,714
$
—
$
1,029,714
Liabilities:
Interest rate contracts
$
—
$
5,149
$
—
$
5,149
Total liabilities
$
—
$
5,149
$
—
$
5,149
Assets Measured on a Non-Recurring Basis:
The following methods and assumptions were used to estimate the fair values of the Company’s assets measured at fair value on a non-recurring basis at March 31, 2026 and June 30, 2025:
Individually Analyzed Collateral Dependent Loans
The fair value of collateral dependent loans that are individually analyzed is determined based upon the appraised fair value of the underlying collateral, less costs to sell. Such collateral primarily consists of real estate and, to a lesser extent, other business assets. Management may also adjust appraised values to reflect estimated changes in market values or apply other adjustments to appraised values resulting from its knowledge of the collateral. Internal valuations may be utilized to determine the fair value of other business assets. For non-collateral-dependent loans, management estimates fair value using discounted cash flows based on inputs that are largely unobservable and instead reflect management’s own estimates of the assumptions as a market participant would in pricing such loans. Individually analyzed collateral dependent loans are considered a Level 3 valuation by the Company.
Those assets measured at fair value on a non-recurring basis are summarized below:
March 31, 2026
Quoted Prices in Active Markets for Identical Assets (Level 1)
Significant Other Observable Inputs (Level 2)
Significant Unobservable Inputs (Level 3)
Total
(In Thousands)
Collateral dependent loans:
Multi-family mortgage
$
—
$
—
$
18,748
$
18,748
Nonresidential mortgage
—
—
4,697
4,697
Total
$
—
$
—
$
23,445
$
23,445
June 30, 2025
Quoted Prices in Active Markets for Identical Assets (Level 1)
Significant Other Observable Inputs (Level 2)
Significant Unobservable Inputs (Level 3)
Total
(In Thousands)
Collateral dependent loans:
Multi-family mortgage
$
—
$
—
$
16,385
$
16,385
Nonresidential mortgage
—
—
4,697
4,697
Total
$
—
$
—
$
21,082
$
21,082
The following tables present additional quantitative information about assets measured at fair value on a non-recurring basis and for which the Company has utilized adjusted Level 3 inputs to determine fair value:
March 31, 2026
Fair Value
Valuation Techniques
Unobservable Input
Range
Weighted Average
(Dollars in Thousands)
Collateral dependent loans:
Multi-family mortgage
$
18,748
Market valuation of underlying collateral
(1)
Adjustments to reflect current conditions/selling costs
(2)
6.00% - 25.00%
12.63
%
Nonresidential mortgage
4,697
Market valuation of underlying collateral
(1)
Adjustments to reflect current conditions/selling costs
(2)
9.31%
9.31
%
Total
$
23,445
June 30, 2025
Fair Value
Valuation Techniques
Unobservable Input
Range
Weighted Average
(Dollars in Thousands)
Collateral dependent loans:
Multi-family mortgage
$
16,385
Market valuation of underlying collateral
(1)
Adjustments to reflect current conditions/selling costs
(2)
6.00% - 24.00%
15.08
%
Nonresidential mortgage
4,697
Market valuation of underlying collateral
(1)
Adjustments to reflect current conditions/selling costs
(2)
9.44%
9.44
%
Total
$
21,082
___________________________________
(1)The fair value of collateral dependent loans is generally determined based on an independent appraisal of the fair value of a loan’s underlying collateral.
(2)The fair value basis of collateral dependent loans is adjusted to reflect management’s estimates of selling costs including, but not limited to, real estate brokerage commissions and title transfer fees.
At March 31, 2026, collateral dependent loans valued using Level 3 inputs comprised loans with principal balances totaling $24.3 million and a valuation allowance of $886,000 reflecting an aggregate fair value of $23.4 million. By comparison, at June 30, 2025, collateral dependent loans valued using Level 3 inputs comprised loans with principal balances totaling $22.5 million and a valuation allowance of $1.4 million reflecting an aggregate fair value of $21.1 million.
Once a loan is foreclosed, the fair value of the other real estate owned continues to be evaluated based upon the fair value of the repossessed real estate originally securing the loan. At March 31, 2026 and June 30, 2025, the Company had no other real estate owned assets, respectively.
The following tables present the carrying amount, fair value, and placement in the fair value hierarchy of the Company’s financial instruments as of March 31, 2026 and June 30, 2025:
March 31, 2026
Carrying Amount
Fair Value
Quoted Prices in Active Markets for Identical Assets (Level 1)
Quoted Prices in Active Markets for Identical Assets (Level 1)
Significant Other Observable Inputs (Level 2)
Significant Unobservable Inputs (Level 3)
(In Thousands)
Financial assets:
Cash and cash equivalents
$
167,269
$
167,269
$
167,269
$
—
$
—
Investment securities available for sale
1,012,969
1,012,969
—
1,012,969
—
Investment securities held to maturity
120,217
106,712
—
106,712
—
Loans held-for-sale
5,931
6,069
—
6,069
—
Net loans receivable
5,766,746
5,309,760
—
—
5,309,760
FHLB Stock
64,261
—
—
—
—
Interest receivable
28,098
28,098
40
6,930
21,128
Interest rate contracts
16,745
16,745
—
16,745
—
Financial liabilities:
Deposits other than certificates of deposits
3,698,643
3,698,643
3,698,643
—
—
Certificates of deposits
1,976,574
1,970,863
—
—
1,970,863
Borrowings
1,256,491
1,257,269
—
—
1,257,269
Interest payable on deposits
5,259
5,259
1,710
—
3,549
Interest payable on borrowings
3,455
3,455
—
—
3,455
Interest rate contracts
5,149
5,149
—
5,149
—
Commitments. The fair value of commitments to fund credit lines and originate or participate in loans held in portfolio or loans held for sale is estimated using fees currently charged to enter into similar agreements taking into account the remaining terms of the agreements and the present creditworthiness of the counterparties. For fixed rate loan commitments, including those relating to loans held for sale that are considered derivative instruments for financial statement reporting purposes, the fair value also considers the difference between current levels of interest and the committed rates. The carrying value, represented by the net deferred fee arising from the unrecognized commitment, and the fair value, determined by discounting the remaining contractual fee over the term of the commitment using fees currently charged to enter into similar agreements with similar credit risk, is not considered material for disclosure.
Limitations. Fair value estimates are made at a specific point in time based on relevant market information and information about the financial instruments. These estimates do not reflect any premium or discount that could result from offering for sale at one time the entire holdings of a particular financial instrument. Because no fair value exists for a significant portion of the financial instruments, fair value estimates are based on judgments regarding future expected loss experience, current economic conditions, risk characteristics of various financial instruments and other factors. These estimates are subjective in nature, involve uncertainties and matters of judgment and, therefore, cannot be determined with precision. Changes in assumptions could significantly affect the estimates.
The fair value estimates are based on existing on-and-off balance sheet financial instruments without attempting to value anticipated future business and the value of assets and liabilities that are not considered financial instruments. Other significant assets and liabilities that are not considered financial assets and liabilities include premises and equipment, and advances from borrowers for taxes and insurance. In addition, the ramifications related to the realization of the unrealized gains and losses can have a significant effect on fair value estimates and have not been considered in any of the estimates.
Finally, reasonable comparability between financial institutions may not be likely due to the wide range of permitted valuation techniques and numerous estimates which must be made given the absence of active secondary markets for many of the financial instruments. This lack of uniform valuation methodologies introduces a greater degree of subjectivity to these estimated fair values.
The components of accumulated other comprehensive loss included in stockholders’ equity at March 31, 2026 and June 30, 2025 are as follows:
March 31, 2026
June 30, 2025
(In Thousands)
Net unrealized loss on securities available for sale
$
(96,834)
$
(112,142)
Tax effect
28,133
32,542
Net of tax amount
(68,701)
(79,600)
Fair value adjustments on derivatives
3,802
9,770
Tax effect
(1,123)
(2,844)
Net of tax amount
2,679
6,926
Benefit plan adjustments
839
946
Tax effect
(245)
(276)
Net of tax amount
594
670
Total accumulated other comprehensive loss
$
(65,428)
$
(72,004)
Other comprehensive income (loss) and related tax effects for the three and nine months ended March 31, 2026 and 2025 are presented in the following table:
Three Months Ended March 31,
Nine Months Ended March 31,
2026
2025
2026
2025
(In Thousands)
Net unrealized holding (loss) gain on securities available for sale
$
(672)
$
13,606
$
15,308
$
17,979
Fair value adjustments on derivatives
2,867
(9,454)
(5,968)
(26,592)
Benefit plans:
Accretion of net actuarial gain (1)
(36)
(26)
(107)
(80)
Net actuarial gain
—
—
—
141
Net change in benefit plan accrued expense
(36)
(26)
(107)
61
Other comprehensive income (loss) before taxes
2,159
4,126
9,233
(8,552)
Tax effect
(624)
(1,157)
(2,657)
2,587
Total other comprehensive income (loss)
$
1,535
$
2,969
$
6,576
$
(5,965)
___________________________________
(1)Represents amounts reclassified out of accumulated other comprehensive loss and included in the computation of net periodic pension expense. See Note 10 - Benefit Plans for additional information.
The following schedule shows the Company’s earnings per share calculations for the periods presented:
Three Months Ended March 31,
Nine Months Ended March 31,
2026
2025
2026
2025
(In Thousands, Except Per Share Data)
Net income
$
10,137
$
6,648
$
29,092
$
19,306
Weighted average number of common shares outstanding - basic
62,908
62,548
62,835
62,478
Effect of dilutive securities
343
165
305
227
Weighted average number of common shares outstanding - diluted
63,251
62,713
63,140
62,705
Basic earnings per share
$
0.16
$
0.11
$
0.46
$
0.31
Diluted earnings per share
$
0.16
$
0.11
$
0.46
$
0.31
Stock options for 2,745,000 and 2,751,902 shares of common stock were not considered in computing diluted earnings per share for the three and nine months ended March 31, 2026 and 2025, respectively, because they were considered anti-dilutive. In addition, 486,665 and 492,947 RSUs were not considered in computing diluted earnings per share for the three months ended March 31, 2026 and March 31, 2025, respectively, and 498,446 and 444,202 RSUs were not considered in computing diluted earnings per share for the nine months ended March 31, 2026 and March 31, 2025, respectively, because they were considered anti-dilutive.
This Quarterly Report on Form 10-Q may include certain forward-looking statements based on current management expectations. Such forward-looking statements may be identified by reference to a future period or periods or by the use of forward-looking terminology, such as “may”, “will”, “believe”, “expect”, “estimate”, “anticipate”, “continue”, or similar terms or variations on those terms, or the negative of those terms. The actual results of the Company could differ materially from those management expectations. This includes statements regarding general economic and geopolitical conditions, including military conflicts, potential recessionary conditions and the imposition of tariffs or other domestic or international governmental policies and any retaliatory responses, legislative and regulatory changes, monetary and fiscal policies of the federal government, the effects of any federal government shutdown, changes in tax policies, rates and regulations of federal, state and local tax authorities and failure to integrate or profitably operate acquired businesses. Additional potential factors include changes in interest rates, the rate of inflation, deposit flows, cost of funds, demand for loan products and financial services, competition and changes in the quality or composition of loan and investment portfolios of the Company. Other factors that could cause future results to vary from current management expectations include changes in accounting principles, policies or guidelines, and other economic, competitive, governmental and technological factors affecting the Company’s operations, markets, products, services and prices. Further description of the risks and uncertainties to the business are included in this Quarterly Report on Form 10-Q and in the Company’s Annual Report on Form 10-K for the year ended June 30, 2025, under “Item 1A. Risk Factors.”
Except as required by applicable law or regulation, the Company does not undertake, and specifically disclaims any obligation, to release publicly the result of any revisions that may be made to any forward-looking statements to reflect events or circumstances after the date of the statements or to reflect the occurrence of anticipated or unanticipated events.
Critical Accounting Policies
Our accounting policies are integral to understanding the results reported. We consider accounting policies that require management to exercise significant judgment or discretion or to make significant assumptions that have, or could have, a material impact on the carrying value of certain assets or on income to be critical accounting policies. At March 31, 2026, there have been no material changes to our critical accounting policies as compared to the critical accounting policies disclosed in our most recent Annual Report on Form 10-K. Reference is made to Item 7 “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in the Company’s Annual Report on Form 10-K for the year ended June 30, 2025.
Comparison of Financial Condition at March 31, 2026 and June 30, 2025
Executive Summary. Total assets decreased $132.8 million to $7.61 billion at March 31, 2026 from $7.74 billion at June 30, 2025. The decrease primarily reflected decreases in net loans receivable, cash and cash equivalents, and investment securities.
Investment Securities. Investment securities available for sale decreased $29.6 million to $983.3 million at March 31, 2026, from $1.01 billion at June 30, 2025. This decrease was driven by principal repayments of $243.2 million, partially offset by purchases of $198.1 million and a $15.3 million increase in the fair value of the portfolio to a net unrealized loss of $96.8 million.
Investment securities held to maturity decreased $9.6 million to $110.6 million at March 31, 2026 from $120.2 million at June 30, 2025. This decrease was driven by principal repayments of $9.7 million.
Additional information regarding our investment securities at March 31, 2026 and June 30, 2025 is presented in Note 4 to the unaudited consolidated financial statements.
Loans Held-for-Sale. Loans held-for-sale totaled $12.2 million at March 31, 2026 as compared to $5.9 million at June 30, 2025 and are reported separately from the balance of net loans receivable. During the nine months ended March 31, 2026, we sold $86.1 million of residential mortgage loans, resulting in a gain on sale of $616,000.
Net Loans Receivable. Net loans receivable decreased $32.3 million, or 0.6%, to $5.73 billion at March 31, 2026 from $5.77 billion at June 30, 2025. Details regarding the change in the loan portfolio, by loan segment, are presented below:
March 31, 2026
June 30, 2025
Increase/ (Decrease)
(In Thousands)
Commercial loans:
Multi-family mortgage
$
2,555,001
$
2,709,654
$
(154,653)
Nonresidential mortgage
1,012,422
986,556
25,866
Commercial business
201,277
138,755
62,522
Construction
207,765
177,713
30,052
Total commercial loans
3,976,465
4,012,678
(36,213)
One- to four-family residential mortgage
1,741,023
1,748,591
(7,568)
Consumer loans:
Home equity loans
61,379
50,737
10,642
Other consumer
2,377
2,533
(156)
Total consumer loans
63,756
53,270
10,486
Total loans
5,781,244
5,814,539
(33,295)
Unaccreted yield adjustments
(2,063)
(1,602)
(461)
Allowance for credit losses
(44,723)
(46,191)
1,468
Net loans receivable
$
5,734,458
$
5,766,746
$
(32,288)
Commercial loan origination volume for the nine months ended March 31, 2026 totaled $284.2 million, comprised of $107.8 million of commercial mortgage loan originations, $90.5 million of commercial business loan originations and construction loan disbursements of $86.0 million. Purchases of commercial business loans totaled $68.7 million for the same period.
One- to four-family residential mortgage loan origination volume, excluding loans held-for-sale, totaled $90.5 million for the nine months ended March 31, 2026. Purchases of residential mortgage loans totaled $36.3 million for the same period. Home equity loan and line of credit origination volume for the same period totaled $29.4 million.
Loan-to-value (“LTV”) ratios are based on current period loan balances and original appraised values at the time of origination unless a current appraisal has been obtained as a result of the loan being deemed collateral dependent and individually analyzed. The following table sets forth the composition of our real estate secured loans indicating the LTV, by loan category, at March 31, 2026 and June 30, 2025:
March 31, 2026
June 30, 2025
Balance
LTV
Balance
LTV
(Dollars in Thousands)
Commercial mortgage loans:
Multi-family mortgage
$
2,555,001
61
%
$
2,709,654
62
%
Nonresidential mortgage(1)
1,012,422
53
986,556
52
Construction
207,765
55
177,713
56
Total commercial mortgage loans
3,775,188
59
3,873,923
59
One- to four-family residential mortgage
1,741,023
61
1,748,591
62
Consumer loans:
Home equity loans
61,379
51
50,737
51
Total mortgage loans
$
5,577,590
59
%
$
5,673,251
60
%
___________________________________
(1)At March 31, 2026 and June 30, 2025, nonresidential mortgage includes $920,630 and $891,995, respectively, of non-owner occupied commercial real estate (“CRE”) loans with an LTV of 53% in each period, and includes $91,792 and $94,561, respectively, of owner occupied CRE loans with an LTV of 47% and 48%, respectively.
Additional information about our loan portfolio at March 31, 2026 and June 30, 2025 is presented in Note 5 to the unaudited consolidated financial statements.
Nonperforming Assets. Nonperforming assets increased $6.8 million to $52.4 million, or 0.69% of total assets, at March 31, 2026, from $45.6 million, or 0.59% of total assets, at June 30, 2025, respectively. The increase in nonperforming assets was largely attributable to an increase in nonperforming multi-family mortgage loans, partially offset by a decrease in nonperforming residential mortgage loans.
Additional information about our nonperforming loans and loan modifications at March 31, 2026 and June 30, 2025 is presented in Note 5 to the unaudited consolidated financial statements.
Allowance for Credit Losses (“ACL”). At March 31, 2026 the ACL totaled $44.7 million, or 0.77% of total loans, compared to $46.2 million, or 0.79% of total loans, at June 30, 2025. The decrease for the nine months ended March 31, 2026 was largely attributable to net charge-offs of $2.3 million, partially offset by a provision for credit losses of $876,000.
Additional information about our ACL at March 31, 2026 and June 30, 2025 is presented in Note 6 to the unaudited consolidated financial statements.
Other Assets. The aggregate balance of other assets, including premises and equipment, FHLB stock, interest receivable, goodwill, core deposit intangibles, bank owned life insurance (“BOLI”), deferred income taxes, and other assets, decreased $24.0 million to $643.3 million at March 31, 2026 from $667.3 million at June 30, 2025. The decrease in the balance of these other assets during the nine months ended March 31, 2026 primarily reflected a decrease in the market value of interest rate derivatives, a decrease in FHLB stock and a decrease in properties held for sale, partially offset by an increase in BOLI. The remaining change generally reflected normal operating fluctuations within these line items.
Deposits. Total deposits increased $53.9 million, or 0.9%, to $5.73 billion at March 31, 2026 from $5.68 billion at June 30, 2025. Included in total deposits are retail and brokered time deposits of $1.20 billion and $757.2 million, respectively, at March 31, 2026, and $1.22 billionand $757.7 million, respectively, at June 30, 2025. The increase in non-interest bearing demand deposits was largely the result of migrating $69.8 million from a consumer interest bearing product to a non-interest bearing product as part of our repricing strategy. The following table sets forth the distribution of, and changes in, deposits, by type, for the periods indicated:
March 31, 2026
June 30, 2025
Increase/ (Decrease)
(In Thousands)
Non-interest-bearing deposits
$
631,506
$
582,045
$
49,461
Interest-bearing deposits:
Interest-bearing demand
2,375,565
2,362,222
13,343
Savings
763,016
754,376
8,640
Certificates of deposit (retail)
1,201,752
1,218,920
(17,168)
Certificates of deposit (brokered)
757,243
757,654
(411)
Interest-bearing deposits
5,097,576
5,093,172
4,404
Total deposits
$
5,729,082
$
5,675,217
$
53,865
Uninsured deposits totaled $2.20 billion as of March 31, 2026 compared to $1.99 billion as of June 30, 2025. Excluding collateralized deposits of state and local governments, and deposits of the Bank’s wholly-owned subsidiary and holding company, uninsured deposits totaled $839.0 million, or 14.7% of total deposits, at March 31, 2026 compared to $813.8 million, or 14.3% of total deposits, at June 30, 2025.
Additional information about our deposits at March 31, 2026 and June 30, 2025 is presented in Note 7 to the unaudited consolidated financial statements.
Borrowings. The balance of borrowings decreased by $196.5 million to $1.06 billion at March 31, 2026 from $1.26 billion at June 30, 2025, reflecting reductions in FHLB advances.
At March 31, 2026, we maintained available secured borrowing capacity with the FHLB and the Federal Reserve Discount Window of $2.45 billion, representing 32.2% of total assets.
Additional information about our borrowings at March 31, 2026 and June 30, 2025 is presented in Note 8 to the unaudited consolidated financial statements.
Other Liabilities. The balance of other liabilities, including advance payments by borrowers for taxes and other miscellaneous liabilities, decreased $7.2 million to $55.5 million at March 31, 2026 from $62.8 million at June 30, 2025. The change in the balance of these other liabilities generally reflected normal operating fluctuations during the period.
Stockholders’ Equity. Stockholders’ equity increased $17.1 million to $763.0 million at March 31, 2026 from $746.0 million at June 30, 2025. The increase in stockholders’ equity during the nine months ended March 31, 2026 largely reflected net income of $29.1 million and other comprehensive income of $6.6 million, partially offset by cash dividends of $21.0 million. The other comprehensive income for the nine months ended March 31, 2026 was driven by an increase in the fair value of our available for sale securities, partially offset by a decrease in the fair value of our derivatives portfolio.
At March 31, 2026, book value per share increased by $0.24 to $11.79, while tangible book value per share increased by $0.25 to $10.02. These increases were driven by the increases in stockholders’ equity, as described above.
Comparison of Operating Results for the Quarters Ended March 31, 2026 and March 31, 2025
Net Income. Net income for the quarter ended March 31, 2026 was $10.1 million, or $0.16 per diluted share, compared to $6.6 million, or $0.11 per diluted share, for the quarter ended March 31, 2025. The increase in net income reflected increases in net interest income and non-interest income, partially offset by increases in non-interest expense and income taxes.
Net Interest Income. Net interest income increased by $5.2 million to $39.2 million for the quarter ended March 31, 2026 compared to $34.0 million for the quarter ended March 31, 2025. The increase between the comparative periods resulted from a decrease of $5.4 million in interest expense, partially offset by a decrease of $165,000 in interest income. Included in net interest income for the quarters ended March 31, 2026 and 2025, respectively, was purchase accounting accretion of $552,000 and $511,000, and loan prepayment penalty income of $422,000 and $226,000.
Net interest margin increased 31 basis points to 2.21% for the quarter ended March 31, 2026, from 1.90% for the quarter ended March 31, 2025 reflecting a decrease in the cost and average balances of interest-bearing liabilities and higher average yields on loans receivable, partially offset by a decrease in the average balances of interest-earning assets.
Details regarding the composition of, and changes to, net interest income are presented in the table below which reflects the components of the average balance sheet and of net interest income for the periods indicated. We derived the average yields and costs by dividing income or expense by the average balance of assets or liabilities, respectively, for the periods presented with daily balances used to derive average balances. No tax equivalent adjustments have been made to yield or costs. Non-accrual loans were included in the calculation of average balances, however interest receivable on these loans has been fully reserved for and therefore not included in interest income. The yields and costs set forth below include the effect of deferred fees, discounts and premiums that are amortized or accreted to interest income or expense.
Three Months Ended March 31,
2026
2025
Average Balance
Interest
Average Yield/ Cost
Average Balance
Interest
Average Yield/ Cost
(Dollars in Thousands)
Interest-earning assets:
Loans receivable (1)
$
5,785,095
$
66,310
4.58
%
$
5,805,045
$
64,769
4.46
%
Taxable investment securities (2)
1,194,487
11,425
3.83
1,251,612
12,738
4.07
Tax-exempt securities (2)
5,669
34
2.37
9,135
55
2.43
Other interest-earning assets (3)
106,967
1,400
5.24
110,736
1,773
6.40
Total interest-earning assets
7,092,218
79,169
4.47
7,176,528
79,335
4.42
Non-interest-earning assets
455,725
457,206
Total assets
$
7,547,943
$
7,633,734
Interest-bearing liabilities:
Interest-bearing demand
$
2,402,177
14,081
2.34
$
2,405,974
16,426
2.73
Savings
761,090
2,405
1.26
751,243
2,447
1.30
Certificates of deposit (retail)
1,181,526
9,445
3.20
1,215,767
11,333
3.73
Certificates of deposit (brokered)
755,461
5,114
2.71
730,612
4,706
2.58
Total interest-bearing deposits
5,100,254
31,045
2.43
5,103,596
34,912
2.74
Federal Home Loan Bank advances
861,445
7,662
3.56
1,028,958
9,350
3.63
Other borrowings
133,833
1,226
3.66
93,389
1,030
4.41
Borrowings
995,278
8,888
3.57
1,122,347
10,380
3.70
Total interest-bearing liabilities
6,095,532
39,933
2.62
6,225,943
45,292
2.91
Non-interest-bearing liabilities (4)
693,138
662,566
Total liabilities
6,788,670
6,888,509
Stockholders' equity
759,273
745,225
Total liabilities and stockholders' equity
$
7,547,943
$
7,633,734
Net interest income
$
39,236
$
34,043
Interest rate spread (5)
1.85
%
1.51
%
Net interest margin (6)
2.21
%
1.90
%
Ratio of interest-earning assets to interest-bearing liabilities
1.16
1.15
___________________________________
(1)Loans held-for-sale and non-accruing loans have been included in loans receivable and the effect of such inclusion was not material. Allowance for credit losses has been included in non-interest-earning assets.
(2)Fair value adjustments have been excluded in the balances of interest-earning assets.
(3)Includes interest-bearing deposits at other banks and FHLB of New York capital stock.
(4)Includes average balances of non-interest-bearing deposits of $633.5 million and $602.6 million for the quarter ended March 31, 2026 and 2025, respectively.
(5)Interest rate spread represents the difference between the yield on interest-earning assets and the cost of interest-bearing liabilities.
(6)Net interest margin represents net interest income as a percentage of average interest-earning assets.
Provision for Credit Losses. The provision for credit losses increased $25,000 to $391,000 for the quarter ended March 31, 2026, compared to $366,000 for the quarter ended March 31, 2025. The provision for the quarter ended March 31, 2026 was primarily driven by loan growth and charge-offs associated with certain individually evaluated loans, partially offset by quantitative risk factor adjustments. By comparison, the provision for credit losses for the quarter ended March 31, 2025 was primarily driven by loan charge-offs.
Additional information regarding the ACL and the associated provisions recognized during the quarters ended March 31, 2026 and 2025 is presented in Note 6 to the unaudited consolidated financial statements as well as the Comparison of Financial Condition at March 31, 2026 and June 30, 2025.
Non-Interest Income. Total non-interest income increased $1.5 million to $6.1 million for the quarter ended March 31, 2026, compared to $4.6 million for the quarter ended March 31, 2025.
Fees and service charges increased $349,000 to $922,000 for the quarter ended March 31, 2026, from $573,000 for the quarter ended March 31, 2025, primarily reflecting $252,000 of higher deposit and branch related fee income, and higher loan related fee income of $97,000.
Other income increased $1.1 million to $1.9 million for the quarter ended March 31, 2026, from $869,000 for the quarter ended March 31, 2025, primarily driven by a non-recurring pre-tax gain of $1.0 million on the sale of two former branch locations held for sale in the current period.
The remaining changes in the other components of non-interest income between comparative periods generally reflected normal operating fluctuations within those line items.
Non-Interest Expense. Total non-interest expense increased $1.9 million to $32.3 million for the quarter ending March 31, 2026, compared to $30.4 million the quarter ended March 31, 2025.
Salaries and employee benefits increased $1.6 million to $19.3 million for the quarter ended March 31, 2026, from $17.7 million for the quarter ended March 31, 2025. This increase was primarily driven by higher salary expense due to annual merit increases, a non-recurring severance charge of $205,000 recorded in the current period, and the absence of a $427,000 non-recurring decrease in stock-based compensation recorded in the prior year period.
Net occupancy expense of premises increased $188,000 to $3.3 million for the quarter ended March 31, 2026, from $3.1 million for the quarter ended March 31, 2025. This increase was primarily driven by $118,000 of higher snow removal expenses.
FDIC insurance premiums decreased $148,000 to $1.3 million for the quarter ended March 31, 2026, from $1.5 million for the quarter ended March 31, 2025, primarily driven by higher capital ratios.
Other non-interest expense increased $162,000 to $3.5 million for the quarter ended March 31, 2026, from $3.3 million for the quarter ended March 31, 2025, primarily driven by higher professional fees and loan related legal expenses, partially offset by a decline in fraud losses.
The remaining changes in the other components of non-interest expense between comparative periods generally reflected normal operating fluctuations within those line items.
Provision for Income Taxes. Provision for income taxes increased $1.3 million to $2.5 million for the quarter ended March 31, 2026 from $1.2 million for the quarter ended March 31, 2025, reflecting a higher level of pre-tax income compared to the prior year period.
Effective tax rates for the quarter ended March 31, 2026 and 2025 were 19.8% and 15.3%, respectively. The increase in the effective tax rate was primarily due to higher full year projected taxable income.
Comparison of Operating Results for the Nine Months Ended March 31, 2026 and March 31, 2025
Net Income. Net income for the nine months ended March 31, 2026 was $29.1 million, or $0.46 per diluted share, compared to $19.3 million, or $0.31 per diluted share, for the nine months ended March 31, 2025. The increase in net income primarily reflected increases in net interest income and non-interest income, partially offset by increases in non-interest expense, income tax expense and the provision for credit losses.
Net Interest Income. Net interest income increased by $15.8 million to $114.9 million for the nine months ended March 31, 2026 compared to $99.1 million for the nine months ended March 31, 2025. The increase between the comparative periods resulted from a decrease of $17.6 million in interest expense, partially offset by a decrease of $1.7 million in interest income. Included in net interest income for the nine months ended March 31, 2026 and 2025, respectively, was purchase accounting accretion of $1.6 million and $1.8 million, and loan prepayment penalty income of $1.5 million and $566,000.
Net interest margin increased 31 basis points to 2.15% for the nine months ended March 31, 2026, from 1.84% for the nine months ended March 31, 2025 and reflected a decrease in the cost of interest-bearing liabilities, a decrease in the average balance of borrowings and an increase in the average balance and yields of loans receivable, partially offset by decreases in the average balances of investment securities and other interest-earning assets.
Details regarding the composition of, and changes to, net interest income are presented in the table below which reflects the components of the average balance sheet and of net interest income for the periods indicated. We derived the average yields and costs by dividing income or expense by the average balance of assets or liabilities, respectively, for the periods presented with daily balances used to derive average balances. No tax equivalent adjustments have been made to yield or costs. Non-accrual loans were included in the calculation of average balances, however interest receivable on these loans has been fully reserved for and therefore not included in interest income. The yields and costs set forth below include the effect of deferred fees, discounts and premiums that are amortized or accreted to interest income or expense.
Nine Months Ended March 31,
2026
2025
Average Balance
Interest
Average Yield/ Cost
Average Balance
Interest
Average Yield/ Cost
(Dollars in Thousands)
Interest-earning assets:
Loans receivable(1)
$
5,790,218
$
202,069
4.65
%
$
5,776,020
$
196,507
4.54
%
Taxable investment securities(2)
1,205,679
35,648
3.94
1,284,356
40,925
4.25
Tax-exempt securities(2)
6,145
110
2.39
10,372
185
2.38
Other interest-earning assets(3)
115,468
4,502
5.20
119,756
6,454
7.19
Total interest-earning assets
7,117,510
242,329
4.54
7,190,504
244,071
4.53
Non-interest-earning assets
454,891
461,651
Total assets
$
7,572,401
$
7,652,155
Interest-bearing liabilities:
Interest-bearing demand
$
2,376,945
44,503
2.50
2,333,797
$
51,421
2.94
Savings
758,173
7,705
1.35
710,130
6,504
1.22
Certificates of deposit (retail)
1,198,289
30,606
3.41
1,212,136
36,078
3.97
Certificates of deposit (brokered)
755,820
15,310
2.70
670,633
12,647
2.51
Total interest-bearing deposits
5,089,227
98,124
2.57
4,926,696
106,650
2.89
Federal Home Loan Bank advances
979,975
26,725
3.64
1,147,524
32,257
3.75
Other borrowings
85,584
2,571
4.01
162,810
6,064
4.97
Borrowings
1,065,559
29,296
3.67
1,310,334
38,321
3.90
Total interest-bearing liabilities
6,154,786
127,420
2.76
6,237,030
144,971
3.10
Non-interest-bearing liabilities(4)
664,549
667,188
Total liabilities
6,819,335
6,904,218
Stockholders' equity
753,066
747,937
Total liabilities and stockholders' equity
$
7,572,401
$
7,652,155
Net interest income
$
114,909
$
99,100
Interest rate spread(5)
1.78
%
1.43
%
Net interest margin(6)
2.15
%
1.84
%
Ratio of interest-earning assets to interest-bearing liabilities
1.16
1.15
___________________________________
(1)Loans held-for-sale and non-accruing loans have been included in loans receivable and the effect of such inclusion was not material. Allowance for credit losses has been included in non-interest-earning assets.
(2)Fair value adjustments have been excluded in the balances of interest-earning assets.
(3)Includes interest-bearing deposits at other banks and FHLB of New York capital stock.
(4)Includes average balances of non-interest-bearing deposits of $603.2 million and $602.2 million for the nine months ended March 31, 2026 and 2025, respectively.
(5)Interest rate spread represents the difference between the yield on interest-earning assets and the cost of interest-bearing liabilities.
(6)Net interest margin represents net interest income as a percentage of average interest-earning assets.
Provision for Credit Losses. The provision for credit losses increased $295,000 to $876,000 for the nine months ended March 31, 2026, compared to $581,000 for the nine months ended March 31, 2025. The provision for the nine months ended March 31, 2026 was primarily driven by quantitative risk-factor adjustments and higher reserves on individually evaluated loans, including one non-performing C&I loan that was fully charged off during the period. By comparison, the provision for credit losses for the nine months ended March 31, 2025 was primarily driven by charge-offs and loan growth.
Additional information regarding the ACL and the associated provisions recognized during the nine months ended March 31, 2026 and 2025 is presented in Note 6 to the unaudited consolidated financial statements as well as the Comparison of Financial Condition at March 31, 2026 and June 30, 2025.
Non-Interest Income. Total non-interest income increased $3.5 million to $17.5 million for the nine months ended March 31, 2026, compared to $14.1 million for the nine months ended March 31, 2025.
Fees and service charges increased $1.3 million to $3.1 million for the nine months ended March 31, 2026, compared to $1.8 million for the nine months ended March 31, 2025, primarily reflecting $739,000 of higher deposit and branch related fee income, and higher loan related fee income of $535,000.
Other income increased $2.0 million to $4.5 million for the nine months ended March 31, 2026, compared to $2.5 million for the nine months ended March 31, 2025, primarily driven by non-recurring pre-tax gains of $1.8 million on the sale of three former branch locations held for sale.
The remaining changes in the other components of non-interest income between comparative periods generally reflected normal operating fluctuations within those line items.
Non-Interest Expense. Total non-interest expense increased $5.4 million to $95.2 million for the nine months ended March 31, 2026, compared to $89.7 million for the nine months ended March 31, 2025.
Salaries and employee benefits increased $3.7 million to $56.4 million for the nine months ended March 31, 2026, compared to $52.8 million for the nine months ended March 31, 2025. This increase was primarily driven by higher salary expense and payroll taxes from annual merit increases, an increase in incentive compensation, a non-recurring severance charge of $205,000 recorded in the current period, and the absence of a $427,000 non-recurring decrease in stock-based compensation recorded in the prior year period.
Net occupancy expense of premises increased $754,000 to $9.5 million for the nine months ended March 31, 2026, from $8.7 million for the nine months ended March 31, 2025. This increase was primarily driven by a non-recurring pre-tax expense of $250,000 associated with the consolidation of three branches, non-recurring branch maintenance expenses of $102,000, and higher snow removal expenses of $210,000.
Equipment and systems expense increased $283,000 to $12.0 million for the nine months ended March 31, 2026, from $11.7 million for the nine months ended March 31, 2025, largely attributable to increases in technology expense associated with the Company's ongoing digital banking initiatives.
Advertising and marketing expense increased $377,000 to $1.6 million for the nine months ended March 31, 2026, from $1.3 million for the nine months ended March 31, 2025. This increase primarily reflects normal fluctuations in the timing of campaigns across various advertising formats supporting our loan and deposit growth initiatives.
FDIC insurance premiums decreased $556,000 to $4.0 million for the nine months ended March 31, 2026, from $4.5 million for the nine months ended March 31, 2025, primarily driven by higher capital ratios.
Other non-interest expense increased $1.0 million to $10.8 million for the nine months ended March 31, 2026, compared to $9.8 million for the nine months ended March 31, 2025, primarily driven by $242,000 in non-recurring professional fees incurred in the current period associated with our strategic initiative and partnership with The Lab Consulting, and higher other professional fee and loan related expenses.
The remaining changes in the other components of non-interest expense between comparative periods generally reflected normal operating fluctuations within those line items.
Provision for Income Taxes. Provision for income taxes increased $3.8 million to $7.3 million for the nine months ended March 31, 2026 from $3.5 million for the nine months ended March 31, 2025, reflecting a higher level of pre-tax income compared to the prior year period.
Effective tax rates for the nine months ended March 31, 2026 and 2025 were 20.1% and 15.5%, respectively. The increase in the effective tax rate was primarily due to higher full year projected taxable income.
Liquidity, represented by cash and cash equivalents, is a product of operating, investing and financing activities. Our primary sources of funds are deposits, borrowings, cash flows from investment securities and loans receivable and funds provided from operations. While scheduled payments from the amortization and maturity of loans and investment securities are relatively predictable sources of funds, general interest rates, economic conditions and competition greatly influence deposit flows and prepayments on loans and securities.
At March 31, 2026, liquidity included $123.8 million of short-term cash and cash equivalents and $983.3 million of investment securities available for sale. As of March 31, 2026, we had the capacity to borrow additional cash funds totaling $1.74 billion, comprised of $1.30 billion and $438.5 million from the Federal Reserve discount window and the FHLBNY, respectively, without pledging additional collateral. We had the ability to pledge additional securities to borrow an additional $716.5 million at March 31, 2026. As of that same date, we also had access to unsecured overnight borrowings with other financial institutions totaling $835.0 million, of which none was outstanding.
At March 31, 2026, we had outstanding commitments to originate and purchase loans totaling $113.9 million while such commitments totaled $26.4 million at June 30, 2025. As of those same dates, our pipeline of loans held for sale included $19.3 million and $11.1 million, respectively, of loans in process whose terms included interest rate locks to borrowers that were paired with a best-efforts commitment to sell the loan to a buyer at a fixed price and within a predetermined timeframe after the sale commitment is established.
Construction loans in process and unused lines of credit were $124.4 million and $197.0 million, respectively, at March 31, 2026, compared to $115.7 million and $177.1 million, respectively, at June 30, 2025. We are also subject to the contingent liabilities resulting from letters of credit totaling $115,000 and $160,000 at March 31, 2026 and June 30, 2025, respectively.
Commitments to extend credit are agreements to lend to a customer as long as there is no violation of any condition established in the contract. Commitments generally have fixed expiration dates or other termination clauses and may require payment of a fee by the customer. Our exposure to credit loss in the event of nonperformance by the other party to the financial instrument for commitments to extend credit is represented by the contractual notional amount of those instruments. We use the same credit policies in making commitments and conditional obligations as we do for on-balance-sheet instruments. Since many of the commitments are expected to expire without being drawn upon, the total commitment amounts do not necessarily represent future cash requirements.
Consistent with its goals to operate a sound and profitable financial organization, the Bank actively seeks to maintain its status as a well-capitalized institution in accordance with regulatory standards.
The following table sets forth the Bank’s capital position at March 31, 2026 and June 30, 2025, as compared to the minimum regulatory capital requirements that were in effect as of those dates:
At March 31, 2026
Actual
For Capital Adequacy Purposes
To Be Well Capitalized Under Prompt Corrective Action Provisions
Amount
Ratio
Amount
Ratio
Amount
Ratio
(Dollars in Thousands)
Total capital (to risk-weighted assets)
$
715,570
14.64
%
$
391,080
8.00
%
$
488,850
10.00
%
Tier 1 capital (to risk-weighted assets)
669,697
13.70
%
293,310
6.00
%
391,080
8.00
%
Common equity tier 1 capital (to risk-weighted assets)
669,697
13.70
%
219,983
4.50
%
317,753
6.50
%
Tier 1 capital (to adjusted total assets)
669,697
8.92
%
300,385
4.00
%
375,481
5.00
%
At June 30, 2025
Actual
For Capital Adequacy Purposes
To Be Well Capitalized Under Prompt Corrective Action Provisions
Amount
Ratio
Amount
Ratio
Amount
Ratio
(Dollars in Thousands)
Total capital (to risk-weighted assets)
$
704,969
14.49
%
$
389,184
8.00
%
$
486,481
10.00
%
Tier 1 capital (to risk-weighted assets)
662,232
13.61
%
291,888
6.00
%
389,184
8.00
%
Common equity tier 1 capital (to risk-weighted assets)
The following table sets forth the Company’s capital position at March 31, 2026 and June 30, 2025, as compared to the minimum regulatory capital requirements that were in effect as of those dates:
At March 31, 2026
Actual
For Capital Adequacy Purposes
Amount
Ratio
Amount
Ratio
(Dollars in Thousands)
Total capital (to risk-weighted assets)
$
759,324
15.52
%
$
391,428
8.00
%
Tier 1 capital (to risk-weighted assets)
713,451
14.58
%
293,571
6.00
%
Common equity tier 1 capital (to risk-weighted assets)
713,451
14.58
%
220,178
4.50
%
Tier 1 capital (to adjusted total assets)
713,451
9.48
%
300,995
4.00
%
At June 30, 2025
Actual
For Capital Adequacy Purposes
Amount
Ratio
Amount
Ratio
(Dollars in Thousands)
Total capital (to risk-weighted assets)
$
748,323
15.37
%
$
389,434
8.00
%
Tier 1 capital (to risk-weighted assets)
705,586
14.49
%
292,076
6.00
%
Common equity tier 1 capital (to risk-weighted assets)
705,586
14.49
%
219,057
4.50
%
Tier 1 capital (to adjusted total assets)
705,586
9.23
%
305,661
4.00
%
Off-Balance Sheet Arrangements
In the normal course of our business of investing in loans and securities we are a party to financial instruments with off-balance-sheet risk. These financial instruments include significant purchase commitments, such as commitments related to capital expenditure plans and commitments to extend credit to meet the financing needs of our customers. We had no significant off-balance sheet commitments for capital expenditures as of March 31, 2026.
Recent Accounting Pronouncements
For a discussion of the expected impact of recently issued accounting pronouncements that we have adopted, please refer to Note 3 to the unaudited consolidated financial statements.
QUANTITATIVE AND QUALITATIVE DISCLOSURE ABOUT MARKET RISK
The majority of our assets and liabilities are sensitive to changes in interest rates and as such, interest rate risk is a significant form of market risk that we must manage. Interest rate risk is generally defined in regulatory nomenclature as the risk to earnings or capital arising from the movement of interest rates and arises from several risk factors including re-pricing risk, basis risk, yield curve risk and option risk. We maintain an Asset/Liability Management (“ALM”) program in order to manage our interest rate risk. The program is overseen by the Board of Directors through its Interest Rate Risk Management Committee which has assigned the responsibility for the operational aspects of the ALM program to our Asset/Liability Management Committee (“ALCO”), which is comprised of various members of the senior and executive management team.
The quantitative analysis that we conduct measures interest rate risk from both a capital and earnings perspective. With regard to earnings, movements in interest rates and the shape of the yield curve significantly influence the amount of net interest income (“NII”) that we recognize. Movements in market interest rates, and the effect of such movements on the risk factors noted above, significantly influence the spread between the interest earned on our interest-earning assets and the interest paid on our interest-bearing liabilities. Our internal interest rate risk analysis calculates the sensitivity of our projected NII over a one year period utilizing a static balance sheet assumption through which incoming and outgoing asset and liability cash flows are reinvested into similar instruments. Product pricing and earning asset prepayment speeds are appropriately adjusted for each rate scenario.
With regard to capital, our internal interest rate risk analysis calculates the sensitivity of our Economic Value of Equity (“EVE”) to movements in interest rates. EVE represents the present value of the expected cash flows from our assets less the present value of the expected cash flows arising from our liabilities adjusted for the value of off-balance sheet instruments. EVE attempts to quantify our economic value using a discounted cash flow methodology. The degree to which our EVE changes for any hypothetical interest rate scenario from its base case measurement is a reflection of our sensitivity to interest rate risk.
For both earnings and capital at risk, our interest rate risk analysis calculates a base case scenario that assumes no change in interest rates. The model then measures changes throughout a series of interest rate scenarios representing immediate and permanent, parallel shifts in the yield curve up and down 100, 200 and 300 basis points with additional scenarios modeled where appropriate. The model requires that interest rates remain positive for all points along the yield curve for each rate scenario which may preclude the modeling of certain falling rate scenarios during periods of lower market interest rates.
The following tables present the results of our internal EVE and NII analyses as of March 31, 2026 and June 30, 2025, respectively:
There are numerous internal and external factors that may contribute to changes in our EVE and its sensitivity. Changes in the composition and allocation of our balance sheet, or utilization of off-balance sheet instruments such as derivatives, can significantly alter the exposure to interest rate risk as quantified by the changes in the EVE sensitivity measures. Changes to certain external factors, most notably changes in the level of market interest rates and overall shape of the yield curve, can also alter the projected cash flows of our interest-earning assets and interest-costing liabilities and the associated present values thereof.
Notwithstanding the rate change scenarios presented in the EVE and NII-based analyses above, future interest rates and their effect on net interest income are not predictable. Computations of prospective effects of hypothetical interest rate changes are based on numerous assumptions, including relative levels of market interest rates, prepayments and deposit run-offs and should not be relied upon as indicative of actual results. Certain shortcomings are inherent in this type of computation. Although certain assets and liabilities may have similar maturities or periods of re-pricing, they may react at different times and in different degrees to changes in market interest rates. The interest rate on certain types of assets and liabilities, such as demand deposits and savings accounts, may fluctuate in advance of changes in market interest rates, while rates on other types of assets and liabilities may lag behind changes in market interest rates. Certain assets, such as adjustable-rate mortgages, generally have features which restrict changes in interest rates on a short-term basis and over the life of the asset. In the event of a change in interest rates, prepayments and early withdrawal levels could deviate significantly from those assumed in the analyses set forth above. Additionally, an increase in credit risk may result as the ability of borrowers to service their debt may decrease in the event of an interest rate increase.
ITEM 4.
CONTROLS AND PROCEDURES
As of the end of the period covered by this Report, an evaluation was performed under the supervision and with the participation of the Company’s management, including the Chief Executive Officer and the Chief Financial Officer, of the effectiveness of the design and operation of the Company’s disclosure controls and procedures (as defined in Rule 13a-15(e) and 15d-15(e) promulgated under the Securities Exchange Act of 1934, as amended). Based on that evaluation, the Company’s management, including the Chief Executive Officer and the Chief Financial Officer, concluded that the Company’s disclosure controls and procedures were effective.
During the quarter ended March 31, 2026, there were no changes in the Company’s internal control over financial reporting (as defined in Rule 13a-15(f) under the Securities Exchange Act of 1934) that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.
At March 31, 2026, neither the Company nor the Bank were involved in any pending legal proceedings other than routine legal proceedings occurring in the ordinary course of business, which involve amounts in the aggregate believed by management to be immaterial to the financial condition of the Company and the Bank.
ITEM 1A. Risk Factors
There have been no material changes to the Risk Factors previously disclosed under Item 1A of the Company’s Annual Report on Form 10-K for the year ended June 30, 2025, previously filed with the Securities and Exchange Commission.
ITEM 2. Unregistered Sales of Equity Securities and Use of Proceeds
The Company did not repurchase any shares of its common stock during the three month period ended March 31, 2026.
ITEM 3. Defaults Upon Senior Securities
Not applicable.
ITEM 4. Mine Safety Disclosures
Not applicable.
ITEM 5. Other Information
Securities Trading Plans of Directors and Executive Officers
During the three months ended March 31, 2026, none of our directors or executive officers adopted or terminated any contract, instruction or written plan for the purchase or sale of the Company's securities that was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) or any "non-Rule 10b5-1 trading arrangement.”
The following materials from the Company’s Form 10-Q for the quarter ended March 31, 2026, formatted in Inline XBRL (Extensible Business Reporting Language): (i) the Consolidated Statements of Financial Condition, (ii) the Consolidated Statements of Income; (iii) the Consolidated Statements of Comprehensive Income, (iv) the Consolidated Statements of Changes in Stockholders’ Equity, (v) the Consolidated Statements of Cash Flows and (vi) the Notes to Consolidated Financial Statements.
101.INS
Inline XBRL Instance Document (The instance document does not appear in the interactive data file because its XBRL tags are embedded within the Inline XBRL document)
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
KEARNY FINANCIAL CORP.
Date: May 7, 2026
By:
/s/ Craig L. Montanaro
Craig L. Montanaro
President and Chief Executive Officer
(Principal Executive Officer)
Date: May 7, 2026
By:
/s/ Sean Byrnes
Sean Byrnes
Executive Vice President and Chief Financial Officer